SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CROCE, Carlo Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.370
AS - Asia 10.804
EU - Europa 5.321
SA - Sud America 1.754
AF - Africa 234
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 10
Totale 41.508
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.971
SG - Singapore 4.044
CN - Cina 2.625
BR - Brasile 1.361
VN - Vietnam 1.197
UA - Ucraina 1.037
HK - Hong Kong 985
IT - Italia 853
DE - Germania 821
TR - Turchia 664
GB - Regno Unito 575
PL - Polonia 415
FI - Finlandia 360
FR - Francia 341
BD - Bangladesh 299
SE - Svezia 276
RU - Federazione Russa 269
IN - India 221
JP - Giappone 195
CA - Canada 169
MX - Messico 161
AR - Argentina 146
ID - Indonesia 141
NL - Olanda 86
ZA - Sudafrica 70
IQ - Iraq 68
ES - Italia 66
PK - Pakistan 65
EC - Ecuador 57
CO - Colombia 54
AT - Austria 46
UZ - Uzbekistan 41
VE - Venezuela 41
SA - Arabia Saudita 38
BE - Belgio 35
MA - Marocco 31
PH - Filippine 31
CL - Cile 28
TN - Tunisia 28
MY - Malesia 23
EG - Egitto 22
IR - Iran 22
LT - Lituania 20
CH - Svizzera 19
KE - Kenya 19
KR - Corea 19
BO - Bolivia 17
PY - Paraguay 17
JM - Giamaica 16
UY - Uruguay 16
AE - Emirati Arabi Uniti 15
AU - Australia 15
CZ - Repubblica Ceca 15
ET - Etiopia 14
DZ - Algeria 13
NP - Nepal 13
PE - Perù 13
CR - Costa Rica 10
IL - Israele 10
JO - Giordania 10
RO - Romania 10
AL - Albania 9
GR - Grecia 9
TH - Thailandia 9
AZ - Azerbaigian 8
DO - Repubblica Dominicana 8
HN - Honduras 8
PT - Portogallo 8
IE - Irlanda 7
KZ - Kazakistan 7
LY - Libia 7
PS - Palestinian Territory 7
RS - Serbia 7
HU - Ungheria 6
OM - Oman 6
SV - El Salvador 6
BG - Bulgaria 5
LB - Libano 5
NG - Nigeria 5
PA - Panama 5
SY - Repubblica araba siriana 5
TW - Taiwan 5
EU - Europa 4
MD - Moldavia 4
MN - Mongolia 4
QA - Qatar 4
SN - Senegal 4
AO - Angola 3
BF - Burkina Faso 3
BH - Bahrain 3
BY - Bielorussia 3
DK - Danimarca 3
GT - Guatemala 3
KW - Kuwait 3
LV - Lettonia 3
MU - Mauritius 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BM - Bermuda 2
Totale 41.457
Salva come PNG Salva come JPEG
Città #
Fairfield 2.682
Singapore 2.549
Woodbridge 2.480
Ashburn 2.456
Houston 1.583
San Jose 1.208
Jacksonville 1.146
Seattle 1.061
Chandler 993
Hong Kong 973
Ann Arbor 893
Wilmington 880
Cambridge 859
Santa Clara 754
Beijing 732
Izmir 415
Warsaw 402
Ho Chi Minh City 360
Nanjing 335
Los Angeles 322
Hanoi 255
Dallas 251
Princeton 251
San Diego 234
New York 215
Lauterbourg 204
Boardman 195
Tokyo 183
Ferrara 155
Council Bluffs 145
Milan 144
Munich 142
Addison 121
São Paulo 105
Helsinki 101
Dong Ket 96
Shanghai 96
Mexico City 95
Nanchang 94
Shenyang 92
Jakarta 89
Orem 89
Hefei 82
Dearborn 76
Atlanta 75
Chicago 69
Hebei 68
Tianjin 68
London 65
Buffalo 59
Mountain View 59
Jinan 57
Bremen 55
Da Nang 55
Brooklyn 54
Jiaxing 53
Rome 49
The Dalles 49
Montreal 46
Toronto 46
Denver 45
Haiphong 45
San Francisco 45
Changsha 44
Kunming 43
Rio de Janeiro 43
Turku 42
Hangzhou 41
Johannesburg 41
Chennai 40
Falls Church 40
Moscow 40
Redwood City 40
Columbus 39
Frankfurt am Main 36
Norwalk 36
San Mateo 36
Tashkent 36
Manchester 35
Falkenstein 34
Guangzhou 34
Zhengzhou 33
Nuremberg 32
Phoenix 32
Stockholm 32
Brussels 31
Mumbai 31
Boston 30
Amsterdam 28
Hải Dương 28
Poplar 28
Tappahannock 28
Brasília 27
Orange 27
Philadelphia 27
Belo Horizonte 26
Des Moines 26
Ningbo 26
Verona 24
Washington 24
Totale 28.895
Salva come PNG Salva come JPEG
Nome #
Anti-miR-135b in colon cancer treatment: Results from a preclinical study. 362
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 303
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model 302
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 291
Loss of miR-204 expression is a key event in melanoma 285
13q14 deletion in non-Hodgkin's lymphoma: Correlation with clinicopathologic features 277
13q14 deletions in chronic lymphoproliferative disorders with the t(11;14)(q13;q32): a cytogenetic and interphase cytogenetic study. 276
Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA. 275
Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors 272
A novel t(9;11)(p22;q23) with ALL-1 gene rearrangement associated with progression of a myeloproliferative disorder to acute myeloid leukemia 267
Chromosome aberrations in atypical chronic lymphocytic leukemia: a cytogenetic and interphase cytogenetic study 260
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin 259
Anti-miR-135b in colon cancer treatment: Results from a preclinical study. 259
A set of NF-κB-regulated microRNAs induces acquired TRAIL resistance in Lung cancer 256
A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis 256
MicroRNA expression profiling in human Barrett's carcinogenesis. 255
miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells 253
miRNA signatures associate with pathogenesis and progression of osteosarcoma. 251
Alterations of the tumor suppressor gene ARLTS1 in ovarian cancer 249
Ectopic expression of PLC-β2 in non-invasive breast tumor cells plays a protective role against malignant progression and is correlated with the deregulation of miR-146a 249
MicroRNA involvement in hepatocellular carcinoma 240
A microRNA signature for a BMP2-induced osteoblast lineage commitment program 239
Identification of microRNA activity by Targets' Reverse EXpression. 236
Investigations on microRNAs in human chronic lymphocytic leukemia and control of cancer-associated molecular pathways 235
A microRNA DNA methylation signature for human cancer metastasis 234
MicroRNA e cancro 234
An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues 233
Adenoviral transduction of TESTIN gene into breast and uterine cancer cell lines promotes apoptosis and tumor reduction in vivo 229
Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia 227
Reprogramming of miRNA networks in cancer and leukemia 225
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1 225
miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia 223
The downregulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state. 223
Estrogen Mediated-Activation of miR-191/425 Cluster Modulates Tumorigenicity of Breast Cancer Cells Depending on Estrogen Receptor Status 220
A microRNA signature of hypoxia 219
A mouse model of the fragile gene FHIT: From carcinogenesis to gene therapy and cancer prevention 218
Transcriptional map of 170-kb region at chromosome 11p15.5: Identification and mutational analysis of the BWR1A gene reveals the presence of mutations in tumor samples 218
In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation 217
The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma 216
p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. 215
MicroRNA Expression Profiling in the Histological Subtypes of Barrett's Metaplasia 215
microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer 214
B-cell malignancies in microRNA Eμ-miR-17~92 transgenic mice 212
Insulin growth factor signaling is regulated by microRNA-486, an underexpressed microRNA in lung cancer 211
MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma 210
Identification of differentially expressed microRNAs by microarray: A possible role for microRNA genes in pituitary adenomas 210
PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells 210
Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD 209
Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer 209
Onconase mediated NFKβ downregulation in malignant pleural mesothelioma 207
miR-21 and miR-155 are associated with mitotic activity and lesion depth of borderline melanocytic lesions. 206
MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells 205
MicroRNA-148a reduces tumorigenesis and increases TRAIL-induced apoptosis in NSCLC 204
miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model 203
Intramitochondrial calcium regulation by the FHIT gene product sensitizes to apoptosis 202
Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesis 202
Espressione dei MicroRNA nei carcinomi mammari 201
Strong inverse correlation between MicroRNA-125b and human papillomavirus DNA in productive infection 199
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B 198
Cytogenetic profile of lymphoma of follicle mantle lineage: Correlation with clinicobiologic features 198
Aberrant FHIT transcripts in Merkel cell carcinoma 197
microRNA-135b promotes cancer progression acting as a downstream effector of oncogenic pathways in colon cancer 196
Significance of Aberrant Expression of MicroRNAs in Cancer Cells 195
In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2 195
Cytogenetic and interphase cytogenetic characterization of atypical chronic lymphocytic leukemia carrying BCL1 translocation 195
mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer 194
Gain of imprinting at chromosome 11p15: a pathogenetic mechanism identified in human hepatocarcinomas 194
The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model 194
Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer. 193
MicroRNA-135b promotes cancer progression acting as a downstream effector of oncogenic pathways in colon cancer 193
ALL1 fusion proteins induce deregulation of EphA7 and ERK phosphorylation in human acute leukemias 192
WWOX and p53 dysregulation synergize to drive the development of osteosarcoma 191
Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells 191
Tumor suppressor functions of ARLTS1 in lung cancers 190
Implications of the miR-10 family in chemotherapy response of NPM1-mutated AML 189
Mutated beta-catenin evades a microRNA-dependent regulatory loop 189
Specific microRNAs are downregulated in human thyroid anaplastic carcinomas 188
Extensive modulation of a set of microRNAs in primary glioblastoma 188
Characterization of t(11;14) translocation in mantle cell lymphoma by fluorescent in situ hybridization 187
Knockout mice reveal a tumor suppressor function for Testin 187
MiR-145 participates with TP53 in a death promoting regulatory loop and targets estrogen receptor in human breast cancer cells 184
The role of microRNA genes in papillary thyroid carcinoma 184
TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia 184
Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer 183
WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function 182
Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway 182
MicroRNA-133 controls cardiac hypertrophy 180
MicroRNA deregulation in human thyroid papillary carcinomas 180
MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis 180
MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer 179
Alternative splicing, genomic structure, and fine chromosome localization of REV3L 177
Suppression of MicroRNA-9 by Mutant EGFR signaling upregulates FOXP1 to enhance glioblastoma tumorigenicity 175
Modulation of mismatch repair and genomic stability by miR-155 175
MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells 175
MicroRNA profiles discriminate among colon cancer metastasis 174
MicroRNA genes are frequently located near mouse cancer susceptibility loci 173
Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer 173
Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms 172
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia 172
Oncogenic role of miR-483-3p at the IGF2/483 locus 172
Totale 21.502
Salva come PNG Salva come JPEG
Categoria #
all - tutte 181.124
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.508
Totale 182.632
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.731 124 318 263 67 95 108 151 135 80 201 287 902
2022/20232.423 249 98 61 306 380 391 103 259 323 19 131 103
2023/20241.074 126 169 60 38 79 182 32 69 23 18 30 248
2024/20254.586 144 94 387 137 585 360 160 283 851 471 649 465
2025/202614.174 1.194 650 1.219 1.860 1.889 828 1.714 812 1.523 1.459 726 300
2026/2027255 255 0 0 0 0 0 0 0 0 0 0 0
Totale 41.832